Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.80828 | 34 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.79289 | 35 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.7702 | 34 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.75525 | 35 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.64922 | 31 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.24231 | 48 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.79158 | 33 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.80355 | 36 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.76936 | 35 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.78161 | 35 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.91416 | 40 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.76698 | 35 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.70655 | 31 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.78476 | 35 |